Glenmark Pharmaceuticals Ltd.

Financial

	Glenmark Pharma	Abbott India	Aurobindo Pharma
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	13.0 .	n/a	865.0 .
Number of ANDA's Approved By USFDA	25.0 .	n/a	733.0 .
Domestic Sales Growth - YoY	10.3 %	8.2 %	n/a
R&D as a % of Total Sales	7.3 %	0.02 %	4.7 %
Financials
5 yr Average ROE	3.99 %	30.11 %	12.72 %
5yr average Equity Multiplier	1.78	1.43	1.46
5yr Average Asset Turnover Ratio	0.8	1.14	0.68
5yr Avg Net Profit Margin	2.85 %	18.53 %	12.5 %
Price to Book	6.65	15.21	1.99
P/E	78.05	44.33	19.15
5yr Avg Cash Conversion Cycle	-150.94 Days	-46.68 Days	-46.37 Days
Inventory Days	32.28 Days	45.22 Days	59.62 Days
Days Receivable	32.34 Days	19.34 Days	30.33 Days
Days Payable	201.14 Days	109.21 Days	121.28 Days
5yr Average Interest Coverage Ratio	4.25	97.37	43.54
5yr Avg ROCE	17.54 %	38.77 %	15.27 %
5yr Avg Operating Profit Margin	15.96 %	23.42 %	19.22 %
5 yr average Debt to Equity	0.38	0.0	0.19
5yr CAGR Net Profit	1.54 %	15.41 %	-8.16 %
5yr Average Return on Assets	2.09 %	21.03 %	8.64 %
Shareholdings
Promoter Holding	46.65 %	74.99 %	51.82 %
Share Pledged by Promoters	0.0	0.0	17.08 %
Change in Promoter Holding (3 Yrs)	0.0	0.0	-0.01 %
Change in Mutual Fund Holding (3 Yrs)	9.74 %	2.93 %	9.14 %

Business

	Glenmark Pharma	Abbott India	Aurobindo Pharma
Product Wise Break-Up	Product Wise Break-Up Branded Generics 60.46 Formulations 39.54 Vitamin, Minerals & Nutrition 0 Hepatoprotectives 0 Hormones 0 Anti Diabetic 0 Central Nervous System 0 Respiratory 0 Vaccines 0 cardiovascular system 0 Derma 0 Anti-Infectives 0 Metabolic 0 Women`s health 0 Gastro Intestinal 0 Pain 0 API 0 Formulations 0	Product Wise Break-Up Formulations 0 Branded Generics 0 Hepatoprotectives 0 Women`s health 0 Hormones 11.59 Central Nervous System (CNS) 12.65 Vaccines 0 Derma 0 Anti-Infectives 0 Metabolic 0 Pain 0 API 0 Vitamin, Minerals & Nutrition 0 Respiratory 0 Gastro Intestinal 25.46 cardiovascular system 0 Anti Diabetic 42.82 Others 7.48	Product Wise Break-Up Formulations 88.36 Branded Generics 0 Hepatoprotectives 0 Women`s health 0 Hormones 0 Central Nervous System 0 Vaccines 0 Derma 0 Anti-Infectives 0 Metabolic 0 Pain 0 Active Pharmaceutical Ingredient (API) 11.64 Vitamin, Minerals & Nutrition 0 Respiratory 0 Gastro Intestinal 0 cardiovascular system 0 Anti Diabetic 0
Location Wise Break-Up	Location Wise Break-Up India 38.06 North America 23.88 Europe 20.5 Rest of the World 17.56 Latin America 0 USA 0	Location Wise Break-Up North America 0 Rest of the World 1.19 Latin America 0 USA 0 India 98.81 Europe 0	Location Wise Break-Up North America 0 Rest of the World 17.0 Latin America 0 USA 44.3 India 9.0 Europe 29.7
Asset Break-Up	Asset Break-Up India 49.4 North America 42.56 Rest of the World 4.94 Europe 3.09 Latin America 0 USA 0 Others 0.01	-	Asset Break-Up North America 0 Rest of the World 0 Latin America 0 USA 18.21 India 65.14 Europe 7.85 Others 8.8

Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd.

SIGN UP FOR FREE